Fukuda T - Search Results

1

Cost-effectiveness analysis of lifestyle interventions for preventing kidney disease in patients with type 2 diabetes.

Suzuki Y, Hoshi K, Shiroiwa T, Fukuda T. Suzuki Y, et al. Among authors: fukuda t. Clin Exp Nephrol. 2023 Sep;27(9):728-736. doi: 10.1007/s10157-023-02357-7. Epub 2023 May 17. Clin Exp Nephrol. 2023. PMID: 37195388

2

The model-based cost-effectiveness analysis of 1-year adjuvant trastuzumab treatment: based on 2-year follow-up HERA trial data.

Shiroiwa T, Fukuda T, Shimozuma K, Ohashi Y, Tsutani K. Shiroiwa T, et al. Among authors: fukuda t. Breast Cancer Res Treat. 2008 Jun;109(3):559-66. doi: 10.1007/s10549-007-9679-4. Epub 2007 Jul 28. Breast Cancer Res Treat. 2008. PMID: 17661170

3

Cost-effectiveness analysis of bevacizumab combined with chemotherapy for the treatment of metastatic colorectal cancer in Japan.

Shiroiwa T, Fukuda T, Tsutani K. Shiroiwa T, et al. Among authors: fukuda t. Clin Ther. 2007 Oct;29(10):2256-67. doi: 10.1016/j.clinthera.2007.10.013. Clin Ther. 2007. PMID: 18042483

4

International survey on willingness-to-pay (WTP) for one additional QALY gained: what is the threshold of cost effectiveness?

Shiroiwa T, Sung YK, Fukuda T, Lang HC, Bae SC, Tsutani K. Shiroiwa T, et al. Among authors: fukuda t. Health Econ. 2010 Apr;19(4):422-37. doi: 10.1002/hec.1481. Health Econ. 2010. PMID: 19382128

5

Health utility scores of colorectal cancer based on societal preference in Japan.

Shiroiwa T, Fukuda T, Tsutani K. Shiroiwa T, et al. Among authors: fukuda t. Qual Life Res. 2009 Oct;18(8):1095-103. doi: 10.1007/s11136-009-9513-z. Epub 2009 Jul 21. Qual Life Res. 2009. PMID: 19626462

6

Cost-effectiveness analysis of capecitabine compared with bolus 5-fluorouracil/l-leucovorin for the adjuvant treatment of colon cancer in Japan.

Shiroiwa T, Fukuda T, Shimozuma K, Ohashi Y, Tsutani K. Shiroiwa T, et al. Among authors: fukuda t. Pharmacoeconomics. 2009;27(7):597-608. doi: 10.2165/11310110-000000000-00000. Pharmacoeconomics. 2009. PMID: 19663530

7

Out-of-pocket payment and cost-effectiveness of XELOX and XELOX plus bevacizumab therapy: from the perspective of metastatic colorectal cancer patients in Japan.

Shiroiwa T, Fukuda T, Tsutani K. Shiroiwa T, et al. Among authors: fukuda t. Int J Clin Oncol. 2010 Jun;15(3):256-62. doi: 10.1007/s10147-010-0045-x. Epub 2010 Mar 4. Int J Clin Oncol. 2010. PMID: 20198398

8

Comparison of EQ-5D scores among anthracycline-containing regimens followed by taxane and taxane-only regimens for node-positive breast cancer patients after surgery: the N-SAS BC 02 trial.

Shiroiwa T, Fukuda T, Shimozuma K, Kuranami M, Suemasu K, Ohashi Y, Watanabe T. Shiroiwa T, et al. Among authors: fukuda t. Value Health. 2011 Jul-Aug;14(5):746-51. doi: 10.1016/j.jval.2011.01.007. Epub 2011 Jun 2. Value Health. 2011. PMID: 21839414 Free article. Clinical Trial.

9

Cost-effectiveness of adjuvant FOLFOX therapy for stage III colon cancer in Japan based on the MOSAIC trial.

Shiroiwa T, Takeuchi T, Fukuda T, Shimozuma K, Ohashi Y. Shiroiwa T, et al. Among authors: fukuda t. Value Health. 2012 Mar-Apr;15(2):255-60. doi: 10.1016/j.jval.2011.10.006. Epub 2011 Dec 15. Value Health. 2012. PMID: 22433756 Free article. Clinical Trial.

10

Institutional care versus home care for the elderly in a rural area: cost comparison in rural Japan.

Naomi A, Shiroiwa T, Fukuda T, Murashima S. Naomi A, et al. Among authors: fukuda t. Rural Remote Health. 2012;12:1817. Epub 2012 Sep 13. Rural Remote Health. 2012. PMID: 23039842 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

4,934 results

Search Page

Filters